ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)

This study has been completed.
Study NCT00001959.   Last updated on October 8, 2008.   Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Fibrosis
Focal Glomerulosclerosis
Kidney Failure
Nephrotic Syndrome
Proteinuria
2 Additional conditions recognized in this trial
Glomerulosclerosis, Focal Segmental
Syndrome
3 More general conditions related to this trial
Disease
Glomerulonephritis
Kidney Diseases
Nephritis
Nephrosis
Pathologic Processes
Renal Insufficiency
Signs and Symptoms
Urination Disorders
Urologic Diseases
Urological Manifestations
4 Interventions listed in this trial
Pirfenidone
5 More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antineoplastic Agents
Antirheumatic Agents
Central Nervous System Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
6 Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)




Links to all studies - primarily for crawlers